Runben Biotechnology Co Ltd
SSE:603193
Runben Biotechnology Co Ltd
SSE:603193
Price:
20.95
CNY
2.8%
Market Closed
Market Cap:
¥8.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Runben Biotechnology Co Ltd
SSE:603193
|
CN |
Income Statement
Earnings Waterfall
Runben Biotechnology Co Ltd
Runben Biotechnology Co Ltd
Income Statement
Runben Biotechnology Co Ltd
Runben Biotechnology Co Ltd
Currency: CNY
| Jun-2025 | Sep-2025 | ||
|---|---|---|---|
| Revenue | |||
| Revenue |
1 469
N/A
|
1 518
+3%
|
|
| Gross Profit | |||
| Cost of Revenue |
(634)
|
(651)
|
|
| Gross Profit |
835
N/A
|
867
+4%
|
|
| Operating Income | |||
| Operating Expenses |
(504)
|
(533)
|
|
| Selling, General & Administrative |
(473)
|
(503)
|
|
| Research & Development |
(37)
|
(36)
|
|
| Other Operating Expenses |
6
|
6
|
|
| Operating Income |
331
N/A
|
334
+1%
|
|
| Pre-Tax Income | |||
| Interest Income Expense |
31
|
28
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
|
| Total Other Income |
(0)
|
(0)
|
|
| Pre-Tax Income |
362
N/A
|
362
0%
|
|
| Net Income | |||
| Tax Provision |
(55)
|
(57)
|
|
| Income from Continuing Operations |
308
|
305
|
|
| Net Income (Common) |
308
N/A
|
305
-1%
|
|
| EPS (Diluted) |
0.76
N/A
|
0.75
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
